EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY

EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY

This study was planned to compare outcomes of IV versus oral iron in the treatment of iron deficiency anemia during pregnancy. This study was used to investigate the efficacy of two new formulations of iron both in IV and oral form with fewer side effects. We compared the efficacy of Intravenous Ferric Carboxymaltose with Oral polysaccharide iron complex. The better mode of treatment will be administered in future to treat this condition, that will surely improve the fetal and maternal outcome.

Inclusion Criteria:

• Pregnant women aged 18 -45 years;
• Second trimester (gestational age 14-21 weeks);
• Females having hemoglobin level of < 11 g/dL

Exclusion Criteria:

• Multiple pregnancies,
• A history of multiple allergies, known hypersensitivity to any of the excipients in the investigational drugs,
• Active infections
• Recent red blood cell (RBC) transfusion
• Thalassemia minor